Thomas James — 2019 Investments
2 investments dated 2019 · listed companies and verified rows first · show all
Instapath develops rapid digital pathology microscopy platforms that enable cancer diagnosis from tissue samples in minutes rather than days.
BiotechDeep TechHealthtechMedical DevicesHouston, US
Mei Wang(CEO)inQuincy Brown(CRO)inDavid Tulman(Chief Clinical Officer)inPeter Lawson(CTO)
Co-investorsDraper AssociatesY CombinatorVenture Investment Associates
Lunasonde develops aerial georadiotomography (aGRT) technology that uses low-frequency radar to create 3D compositional images of the subsurface from aircraft, helicopters, drones, and balloons.
AgTechCleantechClimate TechDeep TechEnergyCortaro, US
Jeremiah Pate(Executive Officer, Director, Promoter)inHILLARY PATE(Executive Officer)
Co-investorsActuate VenturesBantam GroupDrive CapitalKluz VenturesPure VenturesTechstars+2 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.








